Pages that link to "Q77531744"
Jump to navigation
Jump to search
The following pages link to Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study (Q77531744):
Displaying 20 items.
- Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction (Q27023839) (← links)
- Oral cancer chemotherapy in paediatric patients: obstacles and potential for development and utilisation (Q33860007) (← links)
- Optimal chemotherapy for leukemia: a model-based strategy for individualized treatment (Q35327001) (← links)
- Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment (Q35848092) (← links)
- Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003. (Q36393968) (← links)
- Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia (Q36988021) (← links)
- Analyses of the combination of 6-MP and dasatinib in cell culture (Q37091715) (← links)
- Induction of acute lymphocytic leukemia differentiation by maintenance therapy (Q37098221) (← links)
- Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics (Q37148784) (← links)
- Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease (Q37149572) (← links)
- Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group (Q37166872) (← links)
- Implementation of TPMT testing (Q37678056) (← links)
- Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines (Q40206072) (← links)
- Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate (Q44140105) (← links)
- Investigating the potential impact of dose banding for systemic anti-cancer therapy in the paediatric setting based on pharmacokinetic evidence. (Q50043715) (← links)
- Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate (Q50476254) (← links)
- Challenges and opportunities in childhood cancer drug development (Q51549131) (← links)
- Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies (Q59128454) (← links)
- Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia. (Q64935179) (← links)
- Role of red blood cells in pharmacokinetics of chemotherapeutic agents (Q73711611) (← links)